[HTML][HTML] The anti-helminthic compound mebendazole has multiple antifungal effects against Cryptococcus neoformans

LS Joffe, R Schneider, W Lopes, R Azevedo… - Frontiers in …, 2017 - frontiersin.org
Cryptococcus neoformans is the most lethal pathogen of the central nervous system. The
gold standard treatment of cryptococcosis, a combination of amphotericin B with 5 …

Fenbendazole Controls In Vitro Growth, Virulence Potential, and Animal Infection in the Cryptococcus Model

HC de Oliveira, LS Joffe, KS Simon… - Antimicrobial Agents …, 2020 - Am Soc Microbiol
The human diseases caused by the fungal pathogens Cryptococcus neoformans and
Cryptococcus gattii are associated with high indices of mortality and toxic and/or cost …

Repurposing and reformulation of the antiparasitic agent flubendazole for treatment of cryptococcal meningoencephalitis, a neglected fungal disease

GL Nixon, L McEntee, A Johnson… - Antimicrobial agents …, 2018 - Am Soc Microbiol
Current therapeutic options for cryptococcal meningitis are limited by toxicity, global supply,
and emergence of resistance. There is an urgent need to develop additional antifungal …

[HTML][HTML] Novel cell-based in vitro screen to identify small-molecule inhibitors against intracellular replication of Cryptococcus neoformans in macrophages

S Samantaray, JN Correia, M Garelnabi, K Voelz… - International Journal of …, 2016 - Elsevier
The fungal pathogen Cryptococcus neoformans poses a major threat to
immunocompromised patients and is a leading killer of human immunodeficiency virus (HIV) …

[HTML][HTML] Repurposing drugs to fast-track therapeutic agents for the treatment of cryptococcosis

M Truong, LG Monahan, DA Carter, IG Charles - PeerJ, 2018 - peerj.com
Many infectious diseases disproportionately affect people in the developing world.
Cryptococcal meningitis is one of the most common mycoses in HIV-AIDS patients, with the …

[HTML][HTML] Terbinafine inhibits Cryptococcus neoformans growth and modulates fungal morphology

CR Guerra, K Ishida, M Nucci… - Memórias do Instituto …, 2012 - SciELO Brasil
Cryptococcus neoformans is an encapsulated fungus that causes cryptococcosis. Central
nervous system infection is the most common clinical presentation followed by pulmonary …

An Antivirulence approach for preventing Cryptococcus neoformans from crossing the blood-brain barrier via novel natural product inhibitors of a fungal …

PA Aaron, K Vu, A Gelli - MBio, 2020 - Am Soc Microbiol
Cryptococcus neoformans (Cn) is the leading cause of fungal meningitis, a deadly disease
with limited therapeutic options. Dissemination to the central nervous system hinges on the …

A repurposing approach identifies off-patent drugs with fungicidal cryptococcal activity, a common structural chemotype, and pharmacological properties relevant to …

A Butts, L DiDone, K Koselny, BK Baxter… - Eukaryotic …, 2013 - Am Soc Microbiol
New, more accessible therapies for cryptococcosis represent an unmet clinical need of
global importance. We took a repurposing approach to identify previously developed drugs …

Efficacy of voriconazole in vitro and in invertebrate model of cryptococcosis

C de Castro Spadari, FWM da Silva de Bastiani… - Archives of …, 2020 - Springer
Cryptococcosis is a common opportunistic infection in patients with advanced HIV infection
and may also affect immunocompetent patients. The available antifungal agents are few and …

Environmental triazole induces cross-resistance to clinical drugs and affects morphophysiology and virulence of Cryptococcus gattii and C. neoformans

RW Bastos, HCS Carneiro, LVN Oliveira… - Antimicrobial agents …, 2018 - Am Soc Microbiol
Cryptococcus gattii and Cryptococcus neoformans are environmental fungi that cause
cryptococcosis, which is usually treated with amphotericin B and fluconazole. However …